$49.99
Join our comprehensive course that guides you through the intricate USDA’s amendments on the movement of genetically engineered organisms, following the Federal Court’s decision to vacate the May 2020 rule. Gain an in-depth understanding of the reinstated pre-May 2020 regulations, compliance procedures, and the implications of this significant legal shift. Equip yourself with essential strategies to navigate the regulatory landscape effectively and ensure adherence to the updated rules.
In this course you will learn the following:
* Understand the implications of the Federal Court’s vacatur on APHIS regulations.
* Identify key requirements and changes in 7 CFR parts 330, 340, and 372.
* Implement actionable steps to comply with the reinstated regulations.
* Recognize the consequences of non-compliance with the final rule.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Failure to take this course may lead to misunderstandings of the reinstated regulations, resulting in potential legal risks and non-compliance penalties.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Movement of Certain Genetically Engineered Organisms.
Key regulatory references include:
Course SKU
FR-25-1383-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Why This Course is Important
Without this course, you may overlook critical FDA requirements for HSV CNS diagnostic devices, risking compliance gaps and delayed market access.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Immunology and Microbiology Devices; Classification of the Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections.
Key regulatory references include:
Course SKU
FR-25-1407-1
Why This Course is Important
Without this course, professionals risk non-compliance with FDA device regulations, potentially delaying device approval, missing out on streamlined market access, and failing to implement critical safety measures that protect patients and support innovative diagnostics.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Hematology and Pathology Devices; Classification of the Fluorescence In Situ Hybridization-Based Detection of Chromosomal Abnormalities From Patients With Hematologic Malignancies.
Key regulatory references include:
Course SKU
FR-25-1406-1
© 2026 CourseAvenue, LLC | All rights reserved.
